A new risk model based on a 11-m6A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancer

A new risk model based on a 11-m6A-related lncRNA signature for predicting prognosis and monitoring immunotherapy for gastric cancer

Abstract Objective N6-methyladenosine (m6A) mRNA modification triggers malignant behaviors of tumor cells and thereby drives malignant progression in gastric cancer (GC). However, data regarding the prognostic values of m6A RNA methylation-related long non-coding RNAs (lncRNAs) in GC are very limite...

Full description

Bibliographic Details
Main Authors: Liangliang Lei, Nannan Li, Pengfei Yuan, Dechun Liu
Format: Article
Language:English
Published: BMC 2022-04-01
Series:BMC Cancer
Subjects:
N6-methyladenosine
Long non-coding RNA
Gastric cancer
Prognosis
Immunotherapy
Online Access:https://doi.org/10.1186/s12885-021-09062-2

Internet

https://doi.org/10.1186/s12885-021-09062-2

Similar Items